Karin Travers

2.7k total citations · 1 hit paper
34 papers, 1.9k citations indexed

About

Karin Travers is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, Karin Travers has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 8 papers in Virology and 6 papers in Oncology. Recurrent topics in Karin Travers's work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers) and PARP inhibition in cancer therapy (4 papers). Karin Travers is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers) and PARP inhibition in cancer therapy (4 papers). Karin Travers collaborates with scholars based in United States, Senegal and United Kingdom. Karin Travers's co-authors include Michael Barza, Max Essex, Phyllis J. Kanki, Souleymane Mboup, Aïssatou Guèye‐Ndiaye, Richard Marlink, Tidiane Siby, Ibrahima Ndoye, Ibou Thior and Jean‐Louis Sankalé and has published in prestigious journals such as Science, The Lancet and Clinical Infectious Diseases.

In The Last Decade

Karin Travers

33 papers receiving 1.8k citations

Hit Papers

Reduced Rate of Disease D... 1994 2026 2004 2015 1994 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1
    1994 432 citations Richard Marlink, Phyllis J. Kanki et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Karin Travers 1.0k 908 362 283 161 34 1.9k
Qinghai Hu 395 0.4× 827 0.9× 674 1.9× 264 0.9× 52 0.3× 84 1.5k
Julie A. Ake 480 0.5× 1.1k 1.2× 765 2.1× 338 1.2× 24 0.1× 92 2.0k
Loredana Sarmati 947 0.9× 1.7k 1.8× 1.2k 3.3× 264 0.9× 42 0.3× 185 3.1k
Edward E. Telzak 254 0.2× 1.7k 1.8× 1.5k 4.2× 113 0.4× 85 0.5× 55 2.5k
Jay R. Kostman 1.2k 1.2× 977 1.1× 1.2k 3.3× 948 3.3× 66 0.4× 92 3.3k
Michael L. Landrum 589 0.6× 873 1.0× 733 2.0× 234 0.8× 13 0.1× 49 1.7k
Alash’le Abimiku 1.1k 1.1× 1.6k 1.8× 957 2.6× 310 1.1× 41 0.3× 99 2.6k
Anuradha Ganesan 1.1k 1.1× 1.4k 1.6× 901 2.5× 281 1.0× 13 0.1× 108 2.9k
Heather B. Jaspan 325 0.3× 920 1.0× 1.0k 2.9× 620 2.2× 123 0.8× 130 3.1k
Antoine Chaillon 905 0.9× 1.5k 1.7× 755 2.1× 154 0.5× 21 0.1× 119 2.3k

Countries citing papers authored by Karin Travers

Since Specialization
Citations

This map shows the geographic impact of Karin Travers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Travers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Travers more than expected).

Fields of papers citing papers by Karin Travers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Travers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Travers. The network helps show where Karin Travers may publish in the future.

Co-authorship network of co-authors of Karin Travers

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Travers. A scholar is included among the top collaborators of Karin Travers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Travers. Karin Travers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zwerling, Alice, et al.. (2024). Opportunities for tuberculosis elimination in the Canadian Arctic: cost-effectiveness of community-wide screening in a remote Arctic community. The Lancet Regional Health - Americas. 40. 100916–100916. 2 indexed citations
2.
3.
Ollendorf, Daniel A., et al.. (2017). The Effectiveness and Value of Palliative Care in the Outpatient Setting. JAMA Internal Medicine. 177(2). 264–264. 11 indexed citations
4.
Weisel, Katja, Chantal Doyen, Meletios Α. Dimopoulos, et al.. (2016). A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation. Leukemia & lymphoma. 58(1). 153–161. 32 indexed citations
5.
Wissinger, Erika, Ingolf Griebsch, Juliane Lungershausen, et al.. (2014). The Humanistic Burden of Head and Neck Cancer: A Systematic Literature Review. PharmacoEconomics. 32(12). 1213–1229. 119 indexed citations
6.
7.
Byrnes, Michael, Ajibade Ashaye, Ike Iheanacho, Karin Travers, & Mirko Sikirica. (2013). Mortality and Survival in Inoperable or Residual/Recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Literature Review. Value in Health. 16(7). A378–A378. 1 indexed citations
8.
Travers, Karin, et al.. (2013). Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey. ClinicoEconomics and Outcomes Research. 5. 189–189. 11 indexed citations
9.
Travers, Karin, et al.. (2013). Burden and management of chronic kidney disease in Japan: systematic review of the literature. International Journal of Nephrology and Renovascular Disease. 6. 1–1. 19 indexed citations
10.
Jiménez, Luis, Neerja Rana, John Amalraj, Kimberly Walker, & Karin Travers. (2012). Validation of the BacT/ALERT(R) 3D System for Rapid Sterility Testing of Biopharmaceutical Samples. PDA Journal of Pharmaceutical Science and Technology. 66(1). 38–54. 16 indexed citations
11.
Travers, Karin, et al.. (2011). PIN11 The Impact of Directly Observed Therapy (DOT) in Patients with Tuberculosis. Value in Health. 14(7). A267–A267. 1 indexed citations
12.
Revicki, Dennis A., Karin Travers, Kathleen W. Wyrwich, et al.. (2011). Humanistic and economic burden of generalized anxiety disorder in North America and Europe. Journal of Affective Disorders. 140(2). 103–112. 116 indexed citations
13.
Barza, Michael & Karin Travers. (2002). Excess Infections Due to Antimicrobial Resistance: The “Attributable Fraction”. Clinical Infectious Diseases. 34(s3). S126–S130. 89 indexed citations
14.
Travers, Karin & Michael Barza. (2002). Morbidity of Infections Caused by Antimicrobial‐Resistant Bacteria. Clinical Infectious Diseases. 34(s3). S131–S134. 144 indexed citations
15.
Bailar, John C. & Karin Travers. (2002). Review of Assessments of the Human Health Risk Associated with the Use of Antimicrobial Agents in Agriculture. Clinical Infectious Diseases. 34(s3). S135–S143. 26 indexed citations
16.
Sarr, Abdoulaye Dieng, Jean-Louis Sankalé, Donald J. Hamel, et al.. (2000). Interaction with Human Immunodeficiency Virus (HIV) Type 2 Predicts HIV Type 1 Genotype. Virology. 268(2). 402–410. 12 indexed citations
17.
Popper, Stephen J., Abdoulaye Dieng Sarr, Karin Travers, et al.. (1999). Lower Human Immunodeficiency Virus (HIV) Type 2 Viral Load Reflects the Difference in Pathogenicity of HIV‐1 and HIV‐2. The Journal of Infectious Diseases. 180(4). 1116–1121. 172 indexed citations
18.
Erdman, Susan E., Phyllis J. Kanki, Frances M. Moore, et al.. (1996). Clusters of Lymphoma in Ferrets. Cancer Investigation. 14(3). 225–230. 23 indexed citations
19.
Kanki, Phyllis J., Karin Travers, Richard Marlink, et al.. (1994). Slower heterosexual spread of HIV-2 than HIV-1. The Lancet. 343(8903). 943–946. 259 indexed citations
20.
Kanki, Phyllis J., Souleymane Mboup, Richard Marlink, et al.. (1992). Prevalence and Risk Determinants of Human Immunodeficiency Virus Type 2 (HIV-2) and Human Immunodeficiency Virus Type 1 (HIV-1) in West African Female Prostitutes. American Journal of Epidemiology. 136(7). 895–907. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qinghai Hu Breakdown of academic impact, for papers by Julie A. Ake Breakdown of academic impact, for papers by Loredana Sarmati Breakdown of academic impact, for papers by Edward E. Telzak Breakdown of academic impact, for papers by Jay R. Kostman Breakdown of academic impact, for papers by Michael L. Landrum Breakdown of academic impact, for papers by Alash’le Abimiku Breakdown of academic impact, for papers by Anuradha Ganesan Breakdown of academic impact, for papers by Heather B. Jaspan Breakdown of academic impact, for papers by Antoine Chaillon
Rankless by CCL
2026